Transcatheter aortic valve replacement (TAVR) by transfemoral access has shown great benefit for different risk groups, but its long-term durability is still uncertain. Available evidence comes from small analysis and a single randomized trial with 280 patients and an 8 year follow-up: the NOTION Trial, where TAVR showed less valvular degeneration than aortic valve replacement (AVR) surgery.<a href="https://solaci.org/en/2022/10/17/surtavi-at-5-years/" title="Read more" >...</a>
One of the main complications of alcohol septal ablation (ASA) is the alteration in the conduction system, which could lead to permanent pacemaker (PPM) implantation. This is mainly due to the relationship between septal perfusion and the conduction system (especially the right bundle branch). The incidence reported in the literature is 7% to 20% of<a href="https://solaci.org/en/2022/10/05/prognosis-after-pacemaker-implantation-in-alcohol-septal-ablation/" title="Read more" >...</a>
Studies have shown that the use of computed tomography cardiac angiography (CTCA) prior invasive coronary angiography (ICA) in patients with prior cardiac artery bypass graft (CABG) might reduce procedural time and post procedure kidney injury. 1 out of 5 patients with ischemic cardiomyopathy and prior CABG need to be assessed with ICA within 3 years<a href="https://solaci.org/en/2022/09/22/tct-2022-bypass-ctca-2/" title="Read more" >...</a>
✔️ Advances in Structural Intervention – SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 – Palabras de Bienvenida – Dr. Guering Eid-Lidt (MEX) 01:53 – Neo-commisural alignment and coronary overlap after TAVI – Dr. Luis Nombela Franco (ESP) 19:17 – Heavily calcified aortic annulus and TAVR – Dr. José Mangione (BRA) 36:15 –<a href="https://solaci.org/en/2022/09/20/advances-in-structural-intervention-solaci-socime-2022-2/" title="Read more" >...</a>
Mitral regurgitation (MR) is the most common valvulopathy: it is present in (at least) 7.5% of patients >75 years old. This pathology can be classified as primary or degenerative MR (DMR) and secondary or functional MR (FMR). FMR can be caused by dilatation of the left atrium (most often due to atrial fibrillation), occurring in<a href="https://solaci.org/en/2022/09/16/is-the-cause-of-mitral-regurgitation-relevant-for-mitraclip/" title="Read more" >...</a>
✔️ Opening Ceremony SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 – Welcoming words – Dr. Guering Eid-Lidt (MEX) 01:41 – Fully understanding our TAVR implantation views and techniques – Dr. Ole de Backer (DNK) 21:51 – Transcatheter interventional heart failure therapies – Dr. Juan Granada (USA) 43:17 – The revolution in the<a href="https://solaci.org/en/2022/09/15/opening-ceremony-solaci-socime-2022-2/" title="Read more" >...</a>
✔️ MITRAL VALVE Session ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 – Welcoming Words – Dr. Jorge Cortés (MEX) 01:16 – TAVR for aortic regurgitation – Dr. Raj Makkar (USA) 18:53 – Reduced leaflet motion: the real clinical impact – Dr. Ole de Backer (DNK) 34:17 – TAVR in bicuspid aortic valve: Clinical evidence<a href="https://solaci.org/en/2022/09/15/structural-selected-topics-in-tavi-solaci-socime-2022-2/" title="Read more" >...</a>
✔️ TAVI Complex Anatomy ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:11 – Welcoming words – Dr. Jorge Cortés (MEX) 01:05 – TAVR in complex anatomy. Which is the limit? – Dr. John Paul Vavalle (USA) 13:27 – TAVR in bicuspid aortic valve – Dr. John Paul Vavalle (USA) 31:27 – Calcified annulus. TAVR or<a href="https://solaci.org/en/2022/09/15/tavi-complex-anatomy-solaci-socime-2022-2/" title="Read more" >...</a>
This study, presented by Dr. Valentin Fuster, focused on the importance of medical treatment compliance, initially showing data from the FOCUS study where the poor compliance observed in patients after an acute myocardial infarction (AMI) event was improved by creating a polypill (aspirin, simvastatin, and ramipril). Based on this, the SECURE randomized study was conducted<a href="https://solaci.org/en/2022/08/30/esc-2022-secure-trial-3/" title="Read more" >...</a>
Percutaneous coronary interventions have improved during the last decade with 15% rate of target vessel failure (TVF) at 5 years according to the latest reports. We are already familiar with the benefits of functional assessment of lesions with FFR and its clinical outcomes. Additionally, low post PCI FFR values (FFR ≤ 0.83-≤0.91) have been associated<a href="https://solaci.org/en/2022/08/24/optimization-by-ivus-after-ffr-guided-pci-are-there-clinical-benefits-for-patients/" title="Read more" >...</a>